Health
US researchers develop COVID-19 spike proteins to identify antibodies, prevent infection – ecns
Researchers at Texas A&M University are developing spike proteins that prevent the SARS-CoV-2 virus from binding to human cells, protecting people from future COVID-19 infections, according to a latest release of the university.
Special: Battle Against Novel CoronavirusResearchers at Texas A&M University are developing spike proteins that prevent the SARS-CoV-2 virus from binding to human cells, protecting people from future COVID-19 infections, according to a latest release of the university.
Researchers are producing spike proteins to identify antibodies that can attach to the SARS-CoV-2 spike protein receptor-binding domain and prevent the virus from binding to key sites, thus obstructing the virus from entering…
Continue Reading
